For clinicians

If you care for patients with PSP, CBD, MSA or another rare neurodegenerative disease, you can tell them about Cortau.

Who to refer

  • Patients with any disease on our list, or an undiagnosed progressive neurological disease
  • Families of patients who have died, especially after a brain donation
  • Patients who already had exome or genome sequencing

What we ask of you

Nothing beyond the referral. Patients and families sign up and consent themselves. With their permission, we may contact you to confirm a diagnosis.

What participants get

Participation is research, not clinical testing. Results are only returned when confirmed by a CLIA-certified laboratory, and only to participants who ask for them.

To request printed materials, email contact@cortau.com.